Cargando…
Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia
BACKGROUND: Hypophosphatasia (HP) is an inborn error of bone metabolism characterized by a genetic defect in the gene encoding the tissue-nonspecific alkaline phosphatase (TNSALP). There is a lack of knowledge as to how the variability and clinical severity of the HP phenotype (especially pain and w...
Autores principales: | Girschick, HJ, Schneider, P, Haubitz, I, Hiort, O, Collmann, H, Beer, M, Shin, YS, Seyberth, HW |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533806/ https://www.ncbi.nlm.nih.gov/pubmed/16803637 http://dx.doi.org/10.1186/1750-1172-1-24 |
Ejemplares similares
-
Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy
por: Girschick, Hermann J, et al.
Publicado: (2007) -
Childhood hypophosphatasia: to treat or not to treat
por: Rush, Eric T.
Publicado: (2018) -
Hypophosphatasia
por: Mornet, Etienne
Publicado: (2007) -
Hypophosphatasia
por: Tournis, Symeon, et al.
Publicado: (2021) -
Dental effects of enzyme replacement therapy in case of childhood-type hypophosphatasia
por: Okawa, Rena, et al.
Publicado: (2021)